Ustar Nets Over $47M In Series E+ Round

Dec 03, 2021•over 3 years ago

Amount Raised

$47 Million

Round Type

series e

Hangzhou

Description

Hangzhou-headquartered biotechnology company Ustar Biotechnologies (Hangzhou) Ltd has raised over 300 million yuan ($47 million) in its Series E+ round, per a company statement on Tuesday.

Company Information

Company

Ustar

Location

Hangzhou, Zhejiang, China

About

The company said its products are widely used in more than 2,000 medical organisations in China, and it is exported to 60 countries.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech